Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The c-MYC proto-oncogene protein is a nuclear phosphoprotein and a member of the basic helix-loop-helix leucine zipper (bHLH-LZ) family of transcription factors. It plays a central role in regulating cell cycle progression, apoptosis, cellular transformation, and metabolism. Abnormalities involving MYC are implicated in many human cancers.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on c-MYC proto-oncogene protein (c-MYC).